About
GridAI Tech
GRDX.US
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Profile
- Company Name
- GridAI Technologies Corp.
- Market
- NasdaqCM
- Founded
- --
- Industry
- --
- Fiscal Year End
- --
- Website
- www.grid-ai.com